Ronald van der Geest

About

Ronald is co-founder of 3D-PharmXchange and heads the team of multi-disciplinary project leaders. He is (co)founder of a number of innovative therapeutic start-ups and has worked as a drug development expert in the life sciences sector for his entire career. He is currently part-time CDO of Treeway and interim part-time CEO of Onicor and fulfils development leadership roles within several other biotech companies.

Experience

• Chief Executive Officer (CEO) & Founder at Onicor
  Jan 2021 - Present · 5 yrs 6 mos

  Developing a novel treatment paradigm against onychmycosis

• Chief Development Officer (CDO) at Treeway
  Aug 2013 - Present · 12 yrs 11 mos

  Breakthrough therapy development for ALS & Alzheimers' disease

• Managing Partner & Head of the multi-disciplinary Project Leaders at 3D-PharmXchange
  Mar 2010 - Present · 16 yrs 4 mos

  3D-PharmXchange offers the Life Science industry strategic and operational support in project and line management. Our approach is highly flexible, yet fully integrated. We focus on value creation along 3Dimensions: time, cost and risks.

• Chief Development Officer (CDO) at Protinhi Therapeutics
  Mar 2018 - Aug 2024 · 6 yrs 6 mos

  Innovative drug development against dengue and zika virus

• Kinesis Pharma BV (5 yrs 2 mos)
  • CDO
    Jan 2007 - Feb 2010 · 3 yrs 2 mos

    Responsible for business development and multidisciplinary project management, leading a team of 3-6 project leaders in various disease areas.

  • COO
    Jan 2005 - Jan 2007 · 2 yrs 1 mo

    Responsible for business development, corporate operations, HR, strategy and communications